These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 7817819

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A, Kalai E, Hadj Salah M, Bouzid K, Zerelli L.
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women.
    Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C.
    J Bone Miner Res; 1992 Nov; 7(11):1307-11. PubMed ID: 1466255
    [Abstract] [Full Text] [Related]

  • 26. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers.
    Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A.
    J Bone Miner Res; 1990 Jun; 5(6):609-18. PubMed ID: 2382586
    [Abstract] [Full Text] [Related]

  • 27. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
    Ho KK, Weissberger AJ.
    J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
    [Abstract] [Full Text] [Related]

  • 28. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F, Nieves J, Shen V, Lindsay R.
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [Abstract] [Full Text] [Related]

  • 29. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [Abstract] [Full Text] [Related]

  • 30. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J, Møller J, Thomas S, Djøseland O, Christiansen JS.
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [Abstract] [Full Text] [Related]

  • 31. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
    Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, Kelnar CJ, Wallace WH.
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
    [Abstract] [Full Text] [Related]

  • 32. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC, Hopkins E, Glorieux FH, Chrousos GP, Reynolds JC, Gundberg CM, Reing CM.
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [Abstract] [Full Text] [Related]

  • 33. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
    Kushida K, Takahashi M, Kawana K, Inoue T.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
    [Abstract] [Full Text] [Related]

  • 34. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
    Smilic TN, Novakovic TR, Markovic-Jovanovic SR, Smilic LLJ, Mitic JS, Radunovic ML.
    J Clin Densitom; 2018 Aug; 21(3):322-328. PubMed ID: 29103946
    [Abstract] [Full Text] [Related]

  • 35. Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosis.
    Hasling C, Eriksen EF, Melkko J, Risteli L, Charles P, Mosekilde L, Risteli J.
    J Bone Miner Res; 1991 Dec; 6(12):1295-300. PubMed ID: 1724340
    [Abstract] [Full Text] [Related]

  • 36. Bone turnover in spinal osteoporosis.
    Pødenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C.
    J Bone Miner Res; 1987 Dec; 2(6):497-503. PubMed ID: 3502682
    [Abstract] [Full Text] [Related]

  • 37. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.
    Parfitt AM, Simon LS, Villanueva AR, Krane SM.
    J Bone Miner Res; 1987 Oct; 2(5):427-36. PubMed ID: 3455625
    [Abstract] [Full Text] [Related]

  • 38. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids.
    Sanchez CP, Goodman WG, Brandli D, Goldenhersh M, Murray C, Carlton E, Hahn T, Salusky IB.
    J Bone Miner Res; 1995 Jan; 10(1):2-6. PubMed ID: 7747627
    [Abstract] [Full Text] [Related]

  • 39. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
    Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosén T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jørgensen JO, Saccà L.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
    [Abstract] [Full Text] [Related]

  • 40. Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.
    Gram J, Junker P, Nielsen HK, Bollerslev J.
    Bone; 1996 Jun; 18(6):539-44. PubMed ID: 8805994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.